Concepedia

Alan Calleja

AC

Statistics

Publications

4

Citations

592

H-Index

4

Active since

2019

Affiliations

IQVIA (United Kingdom)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Belgium)

Bristol-Myers Squibb (United Kingdom)

Alan Calleja is an author at IQVIA (United Kingdom) specializing in medicine, oncology, and cancer survival analysis.

Publications per year

2019–2022

4

Publications

4

Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis

Thirusha Lane, Marianna Fontana, Ana Martinez–Naharro et al. · Circulation · 2019 · 515 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis

Robert Carroll, Margherita Bortolini, Alan Calleja et al. · BMC Cancer · 2022 · 28 citations · Full text

Medicine, Oncology, Immuno-oncology Pharmacotherapy +12

Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013–2017: A nationwide CAS registry analysis from the I-O Optimise initiative

M. Daumont, Laure Lacoin, John R. Penrod et al. · Lung Cancer · 2021 · 26 citations · Full text

Medicine, Oncology, Cancer Control +16

Bridging the Gap Between RCTs and RWE Through Endpoint Selection

Robert LoCasale, Chris L. Pashos, Nancy A Dreyer et al. · Therapeutic Innovation & Regulatory Science · 2020 · 23 citations · Full text

Pharmacy, Health Policy, Evidence-based Practice +15

1–4 of 4